The Patented Medicine Prices Review Board in Canada has launched the first phase of consultations on the development of new guidelines relating to its contentious drug pricing mechanism.
It has invited stakeholders to participate in policy roundtables scheduled for 5 December (English session) and 6 December (French session),...